Sustained efficacy of dapagliflozin when added to metformin in type 2 diabetes inadequately controlled by metformin monotherapy

被引：0
|
作者：
Bailey, C. J. [1 ]
Gross, J. L. [2 ]
Yadav, M. [3 ]
Iqbal, N. [4 ]
Mansfield, T. A. [4 ]
List, J. F. [4 ]
机构：
[1] Aston Univ, Birmingham B4 7ET, W Midlands, England
[2] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil
[3] Bristol Myers Squibb, Bombay, Maharashtra, India
[4] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
DIABETOLOGIA | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
146
引用
下载
收藏
页码：S67 / S67
页数：1
相关论文
共 50 条
  • [1] The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone
    DeFronzo, Ralph A.
    Hissa, Miguel N.
    Garber, Alan J.
    Gross, Jorge Luiz
    Duan, Raina Yuyan
    Ravichandran, Shoba
    Chen, Roland S.
    DIABETES CARE, 2009, 32 (09) : 1649 - 1655
  • [2] Efficacy and Safety of Linagliptin in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy
    Taskinen, Marja-Riitta
    Rosenstock, Julio
    Tamminen, Ilkka
    Kubiak, Rene
    Patel, Sanjay
    Dugi, Klaus A.
    Woerle, Hans-Juergen
    DIABETES, 2010, 59 : A158 - A158
  • [3] Effect of Dapagliflozin in Patients with inadequately controlled Type 2 Diabetes with Metformin
    Pavlicek, V.
    DIABETOLOGE, 2011, 7 (01): : 37 - 38
  • [4] Efficacy and Tolerability of Vildagliptin in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy
    Goodman, M.
    Thurston, H.
    Penman, J.
    HORMONE AND METABOLIC RESEARCH, 2009, 41 (05) : 368 - 373
  • [5] A phase 3 trial to evaluate the efficacy and safety of chiglitazar added to metformin in Chinese patients with type 2 diabetes inadequately controlled on metformin monotherapy
    Gao, L.
    Ji, L.
    Dong, X.
    Cheng, Z.
    Zhang, X.
    Sun, W.
    Ma, J.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S359 - S360
  • [6] Efficacy of glyburide/metformin tablets versus metformin plus rosiglitazone in patients with Type 2 diabetes inadequately controlled with metformin monotherapy.
    Mohideen, P
    Klein, E
    Bruce, S
    DIABETOLOGIA, 2002, 45 : A242 - A242
  • [7] Efficacy and safety of saxagliptin plus metformin versus acarbose plus metformin in type 2 diabetes patients inadequately controlled with metformin monotherapy
    Du, J.
    Liang, L.
    Fang, H.
    Xu, F.
    Li, W.
    Shen, L.
    Mu, Y.
    DIABETOLOGIA, 2016, 59 : S372 - S372
  • [8] Efficacy of Dapagliflozin + Sitagliptin + Metformin Versus Sitagliptin + Metformin in T2DM Inadequately Controlled on Metformin Monotherapy: A Multicentric Randomized Trial
    Awadhesh Kumar Singh
    Ashok Kumar Das
    L. Sreenivasa Murthy
    Samit Ghosal
    Rakesh Sahay
    K. V. S. Harikumar
    Ganesh Hosahithlu Keshava
    Mayur Agarwal
    G. Vijayakumar
    Pramila Kalra
    Piyush Lodha
    Sambit Das
    Shehla Shaikh
    Soumik Goswami
    T. P. Ajish
    Prashant Kumthekar
    Mihir Upadhyay
    Anthuvan Thamburaj
    Aushili Mahule
    Ashish Prasad
    Abhijit Pednekar
    Advances in Therapy, 2025, 42 (2) : 801 - 812
  • [9] Metformin-glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy
    Garber, A
    Klein, E
    Bruce, S
    Sankoh, S
    Mohideen, P
    DIABETES OBESITY & METABOLISM, 2006, 8 (02): : 156 - 163
  • [10] Dapagliflozin as an add-on to metformin lowers hyperglycaemia in type 2 diabetes patients inadequately controlled with metformin alone
    Bailey, C. J.
    Gross, J. L.
    Bastone, L.
    Bastien, A.
    List, J. F.
    DIABETOLOGIA, 2009, 52 : S76 - S76
12345